A 3-Year-Old Boy with an Xp21 Deletion Syndrome: A Case Report.
Sadeghmousavi S, Shahkarami S, Rayzan E, Ahmed S, Gharalari FH, Rohlfs M, Klein C, Rezaei N.
Sadeghmousavi S, et al.
Endocr Metab Immune Disord Drug Targets. 2022;22(8):881-887. doi: 10.2174/1871530322666220201143656.
Endocr Metab Immune Disord Drug Targets. 2022.
PMID: 35105298